Gleneagles Hospital Kuala Lumpur (GKL) is one of the leading private hospitals in
Malaysia's metropolitan capital of Kuala Lumpur and is a 376-bedded hospital that
offers patients a comfortable ambience with outstanding medical care. A part of IHH
Healthcare, GKL has grown into a highly respected and reputable healthcare service
provider in Malaysia and the Southeast Asian region; providing excellent
professional healthcare services to local and international patients.
Our commitment to excellence is evident through continuous enhancements to our
hospital facilities and investments in cutting-edge technology, setting us apart in
the industry. GKL is committed to the provision of safe and quality healthcare and
is proud to have a team of highly qualified and experienced medical professionals,
consultants, and nurses who go the extra mile to ensure an exceptional patient
experience.
GKL is also home to some of the most advanced medical technologies and procedures
available such as:
Gamma Knife Radiosurgery – A breakthrough in the medical
field; as way to treat not only brain tumours but also vascular malformations and
functional disorders through a minimally invasive way. The treatment procedure is
simple, painless, straightforward and provides better outcomes as compared to
traditional brain surgery.
Da Vinci Si Surgical System – A surgical platform designed to
enable complex surgery by using a minimally invasive approach. Powered by robotic
technology, Da Vinci Si surgical system allows surgeons to perform intricate
surgeries with utmost meticulousness.
Download our E-Corporate Brochure here: https://online.flippingbook.com/view/176133662/
Our CEO
Rachel Yew
Chief Executive Officer,
Gleneagles Hospital Kuala Lumpur
Rachel Yew is the Chief Executive Officer of Gleneagles Hospital Kuala Lumpur.
She has over 20 years’ experience in healthcare operations and finance. She joined IHH Healthcare Malaysia in 2011 as the Senior Manager of Special Projects at the Malaysia Corporate Office. In 2013, she transitioned to the role of Senior Operations Manager, Centre of Excellence at Pantai Hospital Kuala Lumpur and was promoted to Chief Operating Officer that same year. As Chief Operating Officer, she was actively involved in the redevelopment of the hospital’s new 12-storey hospital and ensured the successful completion of the project. This led to her promotion to Chief Executive Officer of Pantai Hospital Cheras in 2014. She assumed the additional role of Chief Executive Officer of Pantai Hospital Klang in 2021.
As Chief Executive Officer, she brought patient-centric improvements to both Pantai Hospital Cheras and Pantai Hospital Klang – expanding services with new offerings such as the Health Screening Unit, Dialysis Unit, Cath lab, Special Care Unit, Isolation Room, and Daycare Unit, to cater to diverse patient needs. She also ensured business growth and sustainability through the strategic recruitment of consultants. As a result, Rachel was promoted to Chief Executive Officer of Gleneagles Hospital Kuala Lumpur in 2024.
In addition to hospital management duties, Rachel is an active member of the Malaysian Society for Quality in Health (MSQH). From 2017 to 2022, she served as the first secretary of the MSQH Committee for three terms.
Since 1996, GKL has provided high-quality healthcare, complemented by friendly and
professional staff. As we strive to deliver excellent healthcare and patient
services to our community, a good measure of our performance is recognised in the
form of awards and accreditation by third-party institutions.
GKL was one of the first private hospitals in Malaysia to be accredited by the
US-based Joint Commission International (JCI); while locally we are accredited by
the Malaysian Society for Quality in Health (MSQH).
JCI since 2010 (5 cycles renewal)
Joint Commission International (JCI)
MSQH since 2013 (6 cycles renewal)
Malaysian Society for Quality in Health(MSQH)
In addition, other recent notable awards that attest to the quality of care at GKL
include:
Newsweek
Top 250 World’s Best Hospital 2024
#1 World’s Best
Hospital 2024 - Malaysia
GlobalHealth Asia-Pacific Awards 2024
Hospital of the Year in Malaysia by GlobalHealth Asia-Pacific 2024
Malaysia Technology
Excellence Awards 2024
Robotics - Healthcare
Frost & Sullivan Awards
2023
Customer Value Leadership Award 2023
Global Health Asia Pacific Awards
2023
Hospital of the Year in Malaysia by GlobalHealth Asia-Pacific 2023
Customer Care Service Provider of the year in Asia-Pacific by
GlobalHealth Asia-Pacific 2023
Endocrinology Service Provider of the year in Asia-Pacific by
GlobalHealth Asia-Pacific 2023
Gastroenterology Service Provider of the year in Asia-Pacific by
GlobalHealth Asia-Pacific 2023
ICU Service Provider of the year in Asia-Pacific by GlobalHealth
Asia-Pacific 2023
Neurology Service Provider of the year in Asia-Pacific by GlobalHealth
Asia-Pacific 2023
Prostate Care Service Provider of the year in Asia-Pacific by
GlobalHealth Asia-Pacific 2023
Reader’s Digest Trusted Brand 2023
Malaysia Health & Wellness Awards 2022
Corporate Social Responsibility
Malaysia Technology Excellence Awards 2023
Medical Technology (Healthcare)
Healthcare Asia Awards 2023
Service Innovation of the Year – Malaysia
Malaysia Health & Wellness Awards
2022
Corporate Social Responsibility
IHH Summit 2022
IHH GCEO Clinical Award for Clinical Effective 2022
Global Health Asia Pacific Awards 2022
Hospital Of The Year In Malaysia 2022
Value Based Hospital Of The Year In Asia-Pacific 2022
Endocrinology Service Provider OF The Year In Asia-Pacific 2022
Bariatric Service Provider Of The Year In Asia-Pacific 2022
Global Health Asia Pacific Awards 2021
Value Based Hospital Of The Year in The Asia-Pacific 2021
Diabetes Service Provider Of The Year In Asia-Pacific 2021
Endocrinology Service Provider Of The Year In Asia-Pacific 2021
Global Health Asia Pacific Awards 2020
Bariatric Service Provider Of The Year In Asia-Pacific 2020
At Gleneagles Hospital Kuala Lumpur, we are committed to conducting business with the
utmost integrity, with a zero-tolerance policy for bribery and corruption.
Our anti-bribery and corruption guidelines (available here) outline the principles that guide our actions
and decisions.
These guidelines serve as a resource for our employees, partners, suppliers, and
stakeholders, providing clear guidance on identifying, preventing, and reporting
instances of bribery and corruption. By adhering to these principles, we contribute
to fostering a culture of trust and integrity within our organisation and beyond.
We encourage all individuals associated with Gleneagles Hospital Kuala Lumpur to
familiarise themselves with these guidelines to promote a culture of ethical conduct
and compliance.
Elevating Healthcare through Value-Driven Outcomes (VDO)
At Gleneagles Hospital Kuala Lumpur, we believe in delivering healthcare that truly
matters. Our commitment to clinical excellence is exemplified through our
Value-Driven Outcomes (VDO) initiatives. Aligned with international standards, our
healthcare professionals drive interventions and enhance treatment value for our
patients. Leveraging data, we ensure accountability and transparency, offering
confidence that Gleneagles Hospital Kuala Lumpur delivers unparalleled
value-for-money services.
Objectives:
- Measuring Outcomes that Matter to Patients
At Gleneagles Hospital Kuala Lumpur, our VDO initiative places a paramount
focus on outcomes that truly impact our patients. We diligently measure and
analyze the results that matter most to individuals, ensuring that their
healthcare journey is centered around achieving meaningful and personalized
goals.
- Using Data to Promote Value Improvement
Data is the cornerstone of our commitment to excellence. Gleneagles Hospital
Kuala Lumpur harnesses the power of data to inform and drive interventions
that enhance the overall value of our treatments. This data-driven approach
allows us to adapt and continuously improve, ensuring that our patients
receive the most effective and personalized care.
- Embarking on Cost Analysis to Reduce Wastage
Recognizing the importance of responsible resource allocation, our VDO
initiative includes a comprehensive cost analysis to identify and minimize
wastage. By optimizing our resources, we aim to provide high-quality
healthcare that is not only effective but also efficient, maximizing the
value for both patients and the healthcare system.
Knee surgery, particularly Total Knee Replacement (TKR), is a complex
procedure, especially for those suffering from knee osteoarthritis. At
Gleneagles Hospital Kuala Lumpur, we recognize the challenges and
prioritize the patient's voice in our approach to outcomes. We
meticulously evaluate each TKR surgery at 3-month and 6-month intervals,
utilizing the Knee Society Score (KSS) to measure and compare results
against Minimal Clinically Important Difference (MCID) and Substantial
Targets.
This precision-driven approach ensures that the impact of TKR transcends
the surgical realm, resulting in significant improvements in both
quality of life and mobility. This exemplifies our commitment to
comprehensive and transformative orthopaedic care.
Patient’s Journey
Patient visits doctor to determine if TKR is
recommended. | Patient is referred for same-day pre-operative
physiotherapy. | PROMs (KSS) survey and pre-operative physiotherapy
are conducted for the patient in rehab. | Patient undergoes surgery in GKL | Physiotherapy is administered for the patient during
admission until discharge. | The patient attends physiotherapy sessions for three
months. *3 months post-surgery PROMs (KSS) survey is
conducted again to assess the patient's progress.
| The patient continues physiotherapy sessions for an
additional three months. *6 months post-surgery PROMs (KSS) survey is
conducted to monitor the patient's progress. |
Patient Reported Outcome Measures (PROMs) Survey
Through our Patient Reported Outcome Measures (PROMs) Survey, we
carefully measure our patient’s perception of health and
functional well-being post-TKR surgery. PROMs are standardized
questionnaires completed by patients, providing insights into health
perception and functional well-being. The hospital conducts these
surveys before and after treatment to understand any changes in the
patient’s condition and quality of life. Working closely with
patients and clinicians, PROMs give us a full picture of our patients'
health and identify opportunities for continuous improvement.
Minimal Clinically Important Difference (MCID)
When it comes to knee surgery, Gleneagles Hospital Kuala Lumpur uses a
benchmark called Minimal Clinically Important Difference (MCID). Our aim
is for patients to see a minimum score increase of 9 points at 3 months
and 40 points at 6 months post-surgery.
One notable achievement is reaching a 100% rate in the MCID
benchmark within 3 and 6 months post-surgery, underscoring substantial
improvements in pain reduction, daily function, and overall quality of
life.
KSS Reference:
2011 Knee Society Scoring System© (2011KSS)
The Knee Society
(https://www.kneesociety.org/the-knee-society-score)
MCID Reference:
Van der Wees, P.J., Wammes, J.J.G., Akkermans,
R.P. et al. Patient-reported health outcomes after total hip and knee
surgery in a Dutch University Hospital Setting: results of twenty years
clinical registry. BMC Musculoskelet Disord 18, 97 (2017).
https://doi.org/10.1186/s12891-017-1455-y
Lizaur-Utrilla, A., Gonzalez-Parreño, S.,
Martinez-Mendez, D. et al. Minimal clinically important differences and
substantial clinical benefits for Knee Society Scores. Knee Surg Sports
Traumatol Arthrosc 28, 1473–1478 (2020).
https://doi.org/10.1007/s00167-019-05543-x
https://d-nb.info/1212656903/34
Anterior Cruciate Ligament Reconstruction (ACLR) is a surgical
intervention aimed at replacing a damaged ligament, requiring a delicate
blend of precision and excellence. At Gleneagles Hospital Kuala Lumpur,
our commitment extends beyond technical proficiency to encompass
stringent adherence to quality indicators.
Our 2023 performance statistics not only reflect exceptional results but
also demonstrate our unwavering focus on patient safety. By surpassing
international benchmarks in key areas such as prophylactic antibiotic
administration, blood transfusion rates, complications, readmission
prevention, and post-operative rehabilitation, we continuously strive to
assure our patients of a level of care that goes above and beyond
established standards.
Patient’s Journey
Patient visits doctor to determine if ACLR is
recommended. | Patient is referred for same-day pre-operative
physiotherapy. | PROMs (KSS) survey and pre-operative physiotherapy
are conducted for the patient in rehab. | Patient undergoes surgery in GKL | Physiotherapy is administered for the patient during
admission until discharge. | The patient attends physiotherapy sessions for three
months. *3 months post-surgery PROMs (KSS) survey is
conducted again to assess the patient's progress.
| The patient continues physiotherapy sessions for an
additional three months. *6 months post-surgery PROMs (KSS) survey is
conducted to monitor the patient's progress. |
ACLR Surgery Outcomes: Insights from 2023 Data Analysis
ACLR International Benchmark Reference:
Annals of Medicine and Surgery: Analysis of
postoperative complications following elective arthroscopic surgeries of
the knee- a retrospective cohort study
The Knee: Complications following anterior
cruciate ligament reconstruction in the English NHS
Knee Surgery, Sports Traumatology, Arthroscopy:
Inpatient admission following anterior cruciate ligament reconstruction
is associated with higher postoperative complications
Knee Surgery, Sports Traumatology, Arthroscopy:
Procedure length is independently associated with overnight hospital
stay and 30-day readmission following anterior cruciate ligament
reconstruction
Arthroscopy, Sports Medicine, and Rehabilitation:
Operative Time Less Than 1.5 Hours, Male Sex, Dependent Functional
Status, Presence of Dyspnea, and Reoperations Within 30 days Are
Independent Risk Factors for Readmission After ACLR
Hysterectomy, a surgical intervention for uterine removal, constitutes a
pivotal decision in women's health. At Gleneagles Hospital Kuala Lumpur,
we comprehend the gravity of this choice and provide tailored care for
conditions like uterine fibroids, endometriosis, abnormal uterine
bleeding, and gynaecologic cancer.
Our dedication to excellence is underscored by our 2022 and 2023
statistics, showcasing minimal complication rates, successful
laparoscopic procedures, and unwavering adherence to international
safety benchmarks.
Inclusion factors for hysterectomy are as follow:
- Total Abdominal Hysterectomy
- Subtotal Abdominal Hysterectomy
- Hysterectomy and removal of adnexa
- Vaginal Hysterectomy including laparoscopically assisted
- Robotic Hysterectomy
- 3D Laparoscopic Hysterectomy
- Laparoscopic Hysterectomy/Laparoscopic Hysterectomy + or +/-
salpingo-oophorectomy
- Laparoscopy and Therapeutic procedures including laser, diathermy
and destruction e.g., endometriosis, adhesiolysis, tubal surgery and
non- cancerous solid tumours
Hysterectomy Outcomes: Insights from 2022 and 2023 Data
Analysis
Hysterectomy International Benchmark Reference:
Blood Transfusion given: https://www.hindawi.com/journals/ogi/2018/3802532/
Conversion to laparotomy: https://www.jmig.org/article/S1553-4650(15)01667-2/fulltext,
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772131/
Complications: https://www.ajog.org/article/S0002-9378(16)30437-9/fulltext#secsectitle0075
Ontario – Quality-based Procedures
Clinical Handbook for Hysterectomy by Ministry of Health &
Long-Term Care
Laparoscopic Cholecystectomy, the surgical removal of the gallbladder, is
one of the many procedures where we implement our Value Driven Outcome
(VDO) approach. At Gleneagles Hospital Kuala Lumpur, we ensure that this
minimally invasive procedure is performed with the utmost precision and
care. By utilizing advanced laparoscopic techniques, we minimize patient
discomfort, reduce recovery times, and enhance overall surgical
outcomes.
Our adherence to stringent quality indicators allows us to maintain high
standards of care and achieve superior clinical results. Patients
undergoing Laparoscopic Cholecystectomy at GKL can expect a seamless
surgical experience with a focus on safety, efficiency, and effective
pain management.
Inclusion factors of Laparoscopic Cholecystectomy are as follow:
- Elective Laparoscopic Cholecystectomy
Exclusion factors of Laparoscopic Cholecystectomy are as follow:
- Emergency (empyema and gangrenous gallbladder)
- Open Cholecystectomy
- Patient under 18 years old
Laparoscopic Cholecystectomy: Insights from 2023 Data
Analysis
Reference
- EASL Clinical Practice Guidelines on the
prevention, diagnosis and treatment of gallstones European
Association for the Study of the Liver (EASL)
- NATIONAL INSTITUTES OF HEALTH Office of
Medical Applications of Research Gallstones and Laparoscopic
Cholecystectomy
- Association of American Physicians and
Surgeons
- Association of Surgeons of Great Britain
& Ireland
- SAGES : https://www.sages.org/safe-cholecystectomy-program/
- National Institute for Health and Care
Excellence (NICE)
Colonoscopy is an essential procedure for maintaining digestive health
and preventing serious conditions. At Gleneagles Hospital Kuala Lumpur,
our experienced gastroenterologists use advanced techniques to examine
the inner lining of the colon and rectum. This procedure helps detect
polyps, tumors, and other abnormalities early, allowing for prompt
intervention.
We prioritize patient safety and comfort at every step of the process.
Our dedicated team ensures a sterile and controlled environment,
adhering to stringent safety protocols to minimize any risk of infection
or complications. Regular colonoscopies are key to early detection and
treatment, providing you with peace of mind and better health outcomes.
Commitment to International Quality Benchmarks
At Gleneagles Hospital Kuala Lumpur, achieving international benchmarks
for several important quality indicators underscores our dedication to
providing top-tier colonoscopy services:
- Cecal Intubation Rate
The cecal intubation rate refers to the percentage of
colonoscopies reaching and visualizing the whole cecum and its
landmark. A complete bowel examination is a prerequisite for
thorough and reliable inspection of the mucosa in search of
suspicious lesions. A low cecal intubation rate is commonly
associated with increased risk of interval colorectal cancer. An
incomplete colonoscopy causes an increase in treatment cost and
patient comfort as the examination needs to be repeated [1].
- Adequate Bowel Preparation Rate
Past studies have demonstrated that the quality of bowel
preparation affects the cecal intubation rate and detection of
adenoma (benign tumours). An inadequate bowel preparation causes
increased costs and patient inconvenience as the procedure needs
to be rescheduled to a later date. An adequate bowel preparation
rate is defined as achieving a Boston Bowel Preparation Rate
Scale (BBPS) score of ≥ 6, with each segment of the bowel
(ascending, transverse and descending) registering a score of
≥ 2 [1].
- Adenoma Detection Rate for patients ≥ 50 years
old
The aim of colonoscopy is to reduce the complications and death
from colorectal cancer via early detection of tumours at an
earlier and more treatable stage and through removal of
pre-cancerous adenomas [2]. Adonomas are non-cancerous (benign
polyps) that have the potential to develop into cancerous
adenomas (adenocarcinoma) [3]. Hence, the Adenoma Detection Rate
(ADR) is utilized to gauge the sufficient inspection at
screening or diagnostic colonoscopy in patients aged 50 and
more. ADR is defined as the proportion of colonoscopies that
detect at least one histologically confirmed colorectal adenoma
or adenocarcinoma [1,2].
Inclusion factors of Colonoscopy are as follow:
- Colonoscopy procedures (fiber optic colonoscopy plus/ minus
excision/ destruction lesion and colonoscopy with polypectomy)
- Patients who are going through gastroscopy and colonoscopy in the
same session
- Elective/ daycare colonoscopies
Exclusion factors of Colonoscopy are as follow:
- Inpatient referrals
- Emergency Colonoscopy
- Patients less than 18 years old
- Patients with hemicolectomy
- Absconded/ AOR (“at own risk’) discharge
Colonoscopy: Overview of 2023 Data Analysis
Reference
- Kaminski MF, Thomas-Gibson S, Bugajski M,
Bretthauer M, Rees CJ, Dekker E, Hoff G, Jover R, Suchanek S,
Ferlitsch M, Anderson J. Performance measures for lower
gastrointestinal endoscopy: a European Society of Gastrointestinal
Endoscopy (ESGE) quality improvement initiative. United European
gastroenterology journal. 2017 Apr;5(3):309-34.
- Corley DA, Jensen CD, Marks AR, Zhao WK, Lee
JK, Doubeni CA, Zauber AG, De Boer J, Fireman BH, Schottinger JE,
Quinn VP. Adenoma detection rate and risk of colorectal cancer and
death. New england journal of medicine. 2014 Apr 3;370(14):1298-306.
- UpToDate. Patient education: Colon polyps
(Beyond the Basics). [Online].; 2019 [cited 2022 August. Available
from: https://www.uptodate.com/contents/colon-polyps-beyond-the-basics
Percutaneous Coronary Intervention (PCI), commonly known as angioplasty, is a minimally invasive procedure used to treat narrowed or blocked coronary arteries, which are responsible for supplying blood to the heart. At Gleneagles Hospital Kuala Lumpur, our highly skilled cardiologists employ cutting-edge technology to perform PCI, helping to restore normal blood flow and reduce the risk of heart attack.
During PCI, a catheter with a small balloon at its tip is inserted through a blood vessel and guided to the site of the blockage. Once in place, the balloon is inflated to widen the artery, often followed by the placement of a stent to keep the artery open. This procedure is performed with precision and care, ensuring patient safety and comfort throughout. PCI not only alleviates symptoms such as chest pain but also significantly improves heart function and quality of life. Our commitment to excellence in cardiovascular care ensures that every patient receives personalized treatment tailored to their specific needs, helping them achieve the best possible outcomes.
Inclusion factors of Percutaneous Coronary Intervention (PCI) are as follow:
- Percutaneous Coronary Intervention
- Percutaneous Coronary Intervention KIV Coronary Angiogram
Exclusion factors of Percutaneous Coronary Intervention (PCI) are as follow:
- Patients admitted for additional procedures other than PCI or Coronary Angiogram
- Absconded/AOR (“at own risk”) discharge
- Patient less than 18 years old and Balloon Therapy without stenting
| 2023 |
Number of PCI procedures | 424 |
Quality Indicators | International Reference Range | 2023 |
Aspirin and / or Thienopyridines prescribed at discharge | 84.3% | 99.5% |
Statins prescribed at discharge | 93.5% | 99.5% |
No Blood Transfusion given during procedure or post- procedure | 96.9% | 99.8% |
No Emergency CABG surgery or emergency repeat PCI during Index Admission | 97.7% | 100% |
No Vascular Complication at puncture site during Index Admission | 99.6% | 99.8% |
No Post procedure neurological stroke during index admission | 99.9% | 100% |
No Post procedure renal failure requiring dialysis during Index Admission | 99.8% | 100% |
No Cardiac-Specific Readmission within 30 days post-procedure | 93.5% | 100% |
No In- Hospital Mortality | 98.1% | 99.3% |
No Group – Wide Serious Reportable Events (SRE) Categories reported | N/A | 100% |
Lesion Success Rate | 96.3% (NCVD Ref) | 100% |
Reference
- Journal of Vascular Surgery: Underutilization of antiplatelet and statin therapy after postoperative myocardial infarction following vascular surgery
- Journal of the American Heart Association: Hospital performance on percutaneous coronary intervention process and outcomes measures
- Journal of Clinical Medicine: Incidence and predictors of unplanned hospital readmission after percutaneous coronary intervention
- Journal of Invasive Cardiology: In-Hospital and 30-Day Mortality After Percutaneous Coronary Intervention in England in the Pre-COVID and COVID Eras
- Circulation: Adoption of Radial Access and Comparison of Outcomes to Femoral Access in Percutaneous Coronary Intervention
In the pursuit of healthcare excellence, Gleneagles Hospital Kuala Lumpur
places a distinct emphasis on a fundamental yet crucial
aspect—hand hygiene. More than just a regulatory requirement, our
commitment to maintaining the highest standards of cleanliness by
embracing the principle of "clean hands save lives."
Through the diligent efforts of our infection control nurses, who conduct
random observations during their daily rounds, we ensure that hand
hygiene practices are upheld across diverse staff members, spanning
nurses, doctors, allied health, and housekeeping personnel, particularly
in patient wards. With an unwavering dedication to this core principle,
our hand hygiene data consistently surpasses industry benchmarks,
reflecting our steadfast commitment to creating a safe and hygienic
environment for the benefit of our patients and the entire healthcare
community.
Hand Hygiene Outcomes: Insights from 2021 to 2023 Data
Analysis
Average Yearly Compliance Rate
2021 - 94.8%
2022 - 96.0%
2023 - 95.8%
*benchmark at 90%
EN
Find A Doctor
Request an Appointment
International Patient
+603 4141 3000
+603 4141 3018
